This week (25-27th Sept) sees the SBNS Autumn meeting taking place in Romford, UK.

Tissuemed will be attending this key meeting for UK neurosurgeons and will be exhibiting its dural sealant film, TissuePatchDural™. TissuePatchDural is indicated as an adjunct for dural closure to prevent CSF leakage. In the four years since CE mark approval and launch, Tissuemed have supplied in excess of 30,000 patches in over 25 countries, with clinical data published by leading centres in Europe, including the UK.

David Mandley, Tissuemed’s CEO commented. “In the period since the last SBNS meeting we have appointed three direct sales staff who are now supporting existing customers and working with new users across the UK from Dundee to Plymouth. Having direct contact with customers in our home market is proving hugely beneficial for all”

For further information relating to TissuePatchDural click here for a copy of the current product brochure.

The Customer Services Department can be contacted via